Zoloft and Hypoperfusion - a phase IV clinical study of FDA data

Summary:

Hypoperfusion is reported as a side effect among people who take Zoloft (sertraline hydrochloride), especially for people who are male, 60+ old, also take Sertraline, and have Faeces hard.

The phase IV clinical study analyzes which people have Hypoperfusion when taking Zoloft. It is created by eHealthMe based on reports of 128,159 people who have side effects when taking Zoloft from the FDA, and is updated regularly.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,798 Zoloft users. Check the latest studies of Zoloft.

What is Hypoperfusion?

Hypoperfusion (decreased blood flow through an organ) is found to be associated with 174 drugs and 349 conditions by eHealthMe. Check the latest studies of Hypoperfusion.

On Aug, 11, 2026

128,159 people reported to have side effects when taking Zoloft.
Among them, 12 people (0.01%) have Hypoperfusion.

Among these 12 people:

What is the gender of people who have Hypoperfusion when taking Zoloft? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Hypoperfusion when taking Zoloft? *

What are other drugs people take besides Zoloft? *

What are other side effects people have besides Hypoperfusion? *

Blood Glucose Increased: 7 people, 58.33%
Fatigue (feeling of tiredness): 7 people, 58.33%
Dyspnea (difficult or laboured breathing): 6 people, 50.00%
Oedema Peripheral (superficial swelling): 6 people, 50.00%
Respiratory Distress (difficulty in breathing): 6 people, 50.00%
Blood Albumin Decreased: 6 people, 50.00%
Fever: 5 people, 41.67%
Confusional State: 5 people, 41.67%
Haematocrit Decreased: 5 people, 41.67%
Headache (pain in head): 5 people, 41.67%

What are the existing conditions these people have? *

Sleep Disorder: 4 people, 33.33%
Pain: 4 people, 33.33%
Faeces Hard: 4 people, 33.33%
B-Cell Type Acute Leukaemia (cancer of the white blood cells): 3 people, 25.00%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Cardiac Failure Congestive: 2 people, 16.67%
Chest Pain: 1 person, 8.33%
Amyotrophic Lateral Sclerosis (nervous system disease that attacks nerve cells called neurons in your brain and spinal cord): 1 person, 8.33%
Arrhythmias (irregular heartbeat): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and have Hypoperfusion?

- Check whether Hypoperfusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zoloft:

Zoloft (138,798 reports)

Hypoperfusion treatments and more:

Hypoperfusion (1,135 reports)

Browse all side effects of Zoloft:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoperfusion:

Hypoperfusion (174 drugs)

Browse all the conditions that are associated with Hypoperfusion:

Hypoperfusion (349 conditions)

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Zoloft) and Zoloft (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.